NIH-funded research R21 grant

Understanding how genetics affect radiation response in cancer treatment

Official title: Germline Genetic Modifiers of Radiation Response

Funded at Sri International · NIH-10741022 · Data updated 2026-11-12

This study is looking at how your genes might affect how well you respond to radiation therapy if you have breast cancer, with the hope of finding ways to adjust treatment to keep you safer and healthier.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionSri International
NIH-funded
Lab location1 site (Menlo Park, United States)
Project startSeptember 19, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$401,125
NIH project number1R21CA274598-01A1
Project IDNIH-10741022 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are breast cancer patients who are undergoing radiation therapy and have diverse genetic backgrounds.

Less likely to help

Patients who are not receiving radiation therapy or those with cancers other than breast cancer may not benefit from this research.

What this research studies

This research investigates how genetic differences among patients influence their response to radiation therapy, particularly in those with breast cancer. By analyzing genetic variants and their association with radiation sensitivity, the study aims to identify patients who may be at higher risk for radiation-induced injuries. Using advanced techniques like genomics and cell culture, researchers will expose normal tissue cells from cancer patients to radiation to observe their responses. The goal is to develop predictive tools that can help tailor radiation doses to minimize harm and improve patient outcomes.

Why it matters

Potential benefit: If successful, this research could lead to personalized radiation therapy that reduces the risk of harmful side effects for cancer patients.

How similar studies have gone: Previous research has shown promise in using genetic profiling to predict patient responses to various treatments, indicating that this approach may yield valuable insights.

Where this research is happening

  • Sri International
    Menlo Park, United States
    Active

Researchers

  • Principal investigator: Mcdonald, John Tyson — Sri International
  • Study coordinator: Mcdonald, John Tyson

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.